ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R 2 ‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma | Zendy

Vitolo U. | Zendy; Witzig T.E. | Zendy; Gascoyne R.D. | Zendy; Scott D.W. | Zendy; Zhang Q. | Zendy; Jurczak W. | Zendy; Özcan M. | Zendy; Hong X. | Zendy; Zhu J. | Zendy; Jin J. | Zendy; Belada D. | Zendy; Bergua J.M. | Zendy; Piazza F. | Zendy; Mócikova H. | Zendy; Molinari A.L. | Zendy; Yoon D.H. | Zendy; Cavallo F. | Zendy; Tani M. | Zendy; Izutsu K. | Zendy; Kato K. | Zendy; Czuczman M. | Zendy; Hersey S. | Zendy; Kilcoyne A. | Zendy; Russo J. | Zendy; Hudak K. | Zendy; Zhang J. | Zendy; Chiappella A. | Zendy; Nowakowski G.S. | Zendy

Premium

ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R 2 ‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma

Author(s) -

Vitolo U.,

Witzig T.E.,

Gascoyne R.D.,

Scott D.W.,

Zhang Q.,

Jurczak W.,

Özcan M.,

Hong X.,

Zhu J.,

Jin J.,

Belada D.,

Bergua J.M.,

Piazza F.,

Mócikova H.,

Molinari A.L.,

Yoon D.H.,

Cavallo F.,

Tani M.,

Izutsu K.,

Kato K.,

Czuczman M.,

Hersey S.,

Kilcoyne A.,

Russo J.,

Hudak K.,

Zhang J.,

Chiappella A.,

Nowakowski G.S.

Publication year - 2019

Publication title -

hematological oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.918

H-Index - 44

eISSN - 1099-1069

pISSN - 0278-0232

DOI - 10.1002/hon.5_2629

Subject(s) - lenalidomide , medicine , diffuse large b cell lymphoma , chop , rituximab , clinical endpoint , placebo , gastroenterology , lymphoma , vincristine , oncology , pathology , randomized controlled trial , chemotherapy , cyclophosphamide , multiple myeloma , alternative medicine

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research